ExceeMatrix
High-tensile Collagen for Ligament and Tendon Repair
Company Overview
Snapshot
Founded in March 2012, ExceeMatrix operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on the development of high-tensile collagen for ligament and tendon repair. In February 2016, ExceeMatrix presented promising results for its ACL implant in an animal study.
Business overview
ExceeMatrix specializes in developing high-strength collagen medical devices utilizing fibers derived from soft corals. These proprietary fibers boast tensile strength superior to human connective tissue. The company leverages its unique technology platform to engineer regenerative implants with advanced mechanical properties, serving the medical devices and biomaterials sectors within the broader Health Tech & Life Sciences industry.
Strategic signal
In February 2016, ExceeMatrix announced promising results from an animal study for its ACL implant. This milestone indicates potential efficacy and safety for its collagen-based regenerative implants, providing a positive signal for future clinical development and investor interest in its biomaterials technology for orthopedic applications.
Log in to access full profile ›Company Intelligence Q&A
- What is ExceeMatrix's core technology?
- ExceeMatrix develops high-strength collagen medical devices using fibers derived from soft corals, which exhibit tensile strength greater than human connective tissue. This proprietary technology platform is used to create regenerative implants with high mechanical properties.
- When was ExceeMatrix founded?
- ExceeMatrix was founded in March 2012.
- What was a significant development for ExceeMatrix?
- In February 2016, ExceeMatrix presented promising results for its ACL implant in an animal study, demonstrating the potential of its regenerative medical devices.
- What markets does ExceeMatrix target?
- ExceeMatrix targets the medical devices, biomaterials, and tissue regeneration markets, focusing on solutions for ligament and tendon repair within the Health Tech & Life Sciences sector.
- What is ExceeMatrix's current funding stage?
- ExceeMatrix is currently in the Pre-Funding stage, indicating it is seeking initial investment to further develop its high-tensile collagen technology for ligament and tendon repair.